← Back to INKT

MiNK Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 14/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/11/2025Mar 2024Filed 14/11/2025
−$3.1−$2.7−$2.9−$4.2−$2.8−$1.8−$2.7−$3.8
−$0.62−$0.57−$0.65−$1.06−$0.70−$0.46−$0.73−$1.10
54.84.44443.73.5

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.